Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L Green

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Medical Economics|April 9, 2009
"Doc, you're fired"!Stephen L Green
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 2002
Straightening of the hair is not pathognomonic for HIV infectionStephen L Green, Douglas L Nelson
Clinical Therapeutics|June 29, 2004
Results of a multicenter, randomized, open-label efficacy and safety study of two doses of tigecycline for complicated skin and skin-structure infections in hospitalized patientsRussell G Postier, Stephen L Green, Stanley R Klein, et al.
HIV Clinical Trials|January 2, 2007
Substitution with lopinavir/ritonavir improves patient-reported outcomes including quality of life in patients who were intolerant to their antiretroviral therapyEduardo Sprinz, Andrade J Neto, Eduardo Bargman, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Medical Economics|April 9, 2009
"Doc, you're fired"!Stephen L Green
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 2002
Straightening of the hair is not pathognomonic for HIV infectionStephen L Green, Douglas L Nelson
Clinical Therapeutics|June 29, 2004
Results of a multicenter, randomized, open-label efficacy and safety study of two doses of tigecycline for complicated skin and skin-structure infections in hospitalized patientsRussell G Postier, Stephen L Green, Stanley R Klein, et al.
HIV Clinical Trials|January 2, 2007
Substitution with lopinavir/ritonavir improves patient-reported outcomes including quality of life in patients who were intolerant to their antiretroviral therapyEduardo Sprinz, Andrade J Neto, Eduardo Bargman, et al.
Pageof 1